Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Puchner

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
RMD Open|February 23, 2025
Incidence of rheumatoid arthritis in Austria: a prospective population-based cohort study in a federal provinceRudolf Puchner, Judith Sautner, Valentin Ritschl, et al.
Plos One|August 14, 2015
Outcome after Reconstruction of the Proximal Tibia--Complications and Competing Risk AnalysisStephan E Puchner, Paul Kutscha-Lissberg, Alexandra Kaider, et al.
BMC Musculoskeletal Disorders|August 24, 2016
Validity of data collected in BIOREG, the Austrian register for biological treatment in rheumatology: current practice of bDMARD therapy in rheumatoid arthritis in AustriaBernhard Rintelen, Jochen Zwerina, Manfred Herold, et al.
BMC Musculoskeletal Disorders|October 8, 2016
Erratum to: Validity of data collected in BIOREG, the Austrian register for biological treatment in rheumatology: current practice of bDMARD therapy in rheumatoid arthritis in AustriaBernhard Rintelen, Jochen Zwerina, Manfred Herold, et al.
BMC Musculoskeletal Disorders|May 7, 2015
Is the state of health of rheumatoid arthritis patients receiving adequate treatment, predictable? - Results of a surveyRudolf Puchner, Hans Peter Brezinschek, Josef Fritz, et al.
Plos One|January 8, 2016
Interface Management between General Practitioners and Rheumatologists-Results of a Survey Defining a Concept for Future Joint RecommendationsRudolf Puchner, Michael Edlinger, Erich Mur, et al.
Clinical Rheumatology|November 12, 2009
The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus projectBurkhard F Leeb, Elke Böttcher, Hans-Peter Brezinschek, et al.
Wiener Klinische Wochenschrift|January 16, 2019
Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and RehabilitationAntonia Puchner, Hans Peter Gröchenig, Judith Sautner, et al.
Arthritis Research & Therapy|February 8, 2024
Prediction of ineffectiveness of biological drugs using machine learning and explainable AI methods: data from the Austrian Biological Registry BioRegDubravka Ukalovic, Burkhard F Leeb, Bernhard Rintelen, et al.
Arthritis Research & Therapy|September 6, 2017
Opportunities and challenges in rheumatology research in Central EuropeZoltán Szekanecz, Branimir Anic, Gábor Héjj, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
RMD Open|February 23, 2025
Incidence of rheumatoid arthritis in Austria: a prospective population-based cohort study in a federal provinceRudolf Puchner, Judith Sautner, Valentin Ritschl, et al.
Plos One|August 14, 2015
Outcome after Reconstruction of the Proximal Tibia--Complications and Competing Risk AnalysisStephan E Puchner, Paul Kutscha-Lissberg, Alexandra Kaider, et al.
BMC Musculoskeletal Disorders|August 24, 2016
Validity of data collected in BIOREG, the Austrian register for biological treatment in rheumatology: current practice of bDMARD therapy in rheumatoid arthritis in AustriaBernhard Rintelen, Jochen Zwerina, Manfred Herold, et al.
BMC Musculoskeletal Disorders|October 8, 2016
Erratum to: Validity of data collected in BIOREG, the Austrian register for biological treatment in rheumatology: current practice of bDMARD therapy in rheumatoid arthritis in AustriaBernhard Rintelen, Jochen Zwerina, Manfred Herold, et al.
BMC Musculoskeletal Disorders|May 7, 2015
Is the state of health of rheumatoid arthritis patients receiving adequate treatment, predictable? - Results of a surveyRudolf Puchner, Hans Peter Brezinschek, Josef Fritz, et al.
Plos One|January 8, 2016
Interface Management between General Practitioners and Rheumatologists-Results of a Survey Defining a Concept for Future Joint RecommendationsRudolf Puchner, Michael Edlinger, Erich Mur, et al.
Clinical Rheumatology|November 12, 2009
The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus projectBurkhard F Leeb, Elke Böttcher, Hans-Peter Brezinschek, et al.
Wiener Klinische Wochenschrift|January 16, 2019
Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and RehabilitationAntonia Puchner, Hans Peter Gröchenig, Judith Sautner, et al.
Arthritis Research & Therapy|February 8, 2024
Prediction of ineffectiveness of biological drugs using machine learning and explainable AI methods: data from the Austrian Biological Registry BioRegDubravka Ukalovic, Burkhard F Leeb, Bernhard Rintelen, et al.
Arthritis Research & Therapy|September 6, 2017
Opportunities and challenges in rheumatology research in Central EuropeZoltán Szekanecz, Branimir Anic, Gábor Héjj, et al.
Pageof 4